Search

Your search keyword '"Cetron, Marty"' showing total 18 results
Start Over Author "Cetron, Marty"
18 results on '"Cetron, Marty"'

1. Use of US Public Health Travel Restrictions during COVID-19 Outbreak on Diamond Princess Ship, Japan, February-April 2020

Author

Medley, Alexandra M., Marston, Barbara J., Toda, Mitsuru, Kobayashi, Miwako, Weinberg, Michelle, Moriarty, Leah F., Jungerman, M. Robynne, Surpris, Amethyst Clare A., Knust, Barbara, Acosta, Anna M., Shockey, Caitlin E., Daigle, David, Schneider, Zachary D., Charles, Julia, Ishizumi, Atsuyoshi, Stewart, Andrea, Vonnahme, Laura A., Brown, Clive, White, Stefanie, Cohen, Nicole J., and Cetron, Marty

Subjects
United States -- Health policy -- Social policy, Diamond Princess (Cruise ship) -- Health aspects, Epidemics -- Control -- Japan, Travel restrictions -- Health aspects, Public health -- Laws, regulations and rules, Government regulation, Health
Abstract

Public health travel restrictions (PHTR) have been used by the United States to reduce the likelihood of transmission of selected communicable diseases aboard aircraft (1). US federal mechanisms used to [...]

Published
2021
Full Text
View/download PDF

3. Airport Exit and Entry Screening for Ebola — August–November 10, 2014

Author

Brown, Clive M., Aranas, Aaron E., Benenson, Gabrielle A., Brunette, Gary, Cetron, Marty, Chen, Tai-Ho, Cohen, Nicole J., Diaz, Pam, Haber, Yonat, Hale, Christa R., Holton, Kelly, Kohl, Katrin, Lee, Amanda W., Palumbo, Gabriel J., Pearson, Kate, Phares, Christina R., Alvarado-Ramy, Francisco, Roohi, Shah, Rotz, Lisa D., Tappero, Jordan, Washburn, Faith M., Watkins, James, and Pesik, Nicki

Published
2014

4. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak — United States, December 31, 2019–February 4, 2020

Author

Patel, Anita, Jernigan, Daniel B., Abdirizak, Fatuma, Abedi, Glen, Aggarwal, Sharad, Albina, Denise, Allen, Elizabeth, Andersen, Lauren, Anderson, Jade, Anderson, Megan, Anderson, Tara, Anderson, Kayla, Bardossy, Ana Cecilia, Barry, Vaughn, Beer, Karlyn, Bell, Michael, Berger, Sherri, Bertulfo, Joseph, Biggs, Holly, Bornemann, Jennifer, Bornstein, Josh, Bower, Willie, Bresee, Joseph, Brown, Clive, Budd, Alicia, Buigut, Jennifer, Burke, Stephen, Burke, Rachel, Burns, Erin, Butler, Jay, Cantrell, Russell, Cardemil, Cristina, Cates, Jordan, Cetron, Marty, Chatham-Stephens, Kevin, Chatham-Stevens, Kevin, Chea, Nora, Christensen, Bryan, Chu, Victoria, Clarke, Kevin, Cleveland, Angela, Cohen, Nicole, Cohen, Max, Cohn, Amanda, Collins, Jennifer, Dahl, Rebecca, Daley, Walter, Dasari, Vishal, Davlantes, Elizabeth, Dawson, Patrick, Delaney, Lisa, Donahue, Matthew, Dowell, Chad, Dyal, Jonathan, Edens, William, Eidex, Rachel, Epstein, Lauren, Evans, Mary, Fagan, Ryan, Farris, Kevin, Feldstein, Leora, Fox, LeAnne, Frank, Mark, Freeman, Brandi, Fry, Alicia, Fuller, James, Galang, Romeo, Gerber, Sue, Gokhale, Runa, Goldstein, Sue, Gorman, Sue, Gregg, William, Greim, William, Grube, Steven, Hall, Aron, Haynes, Amber, Hill, Sherrasa, Hornsby-Myers, Jennifer, Hunter, Jennifer, Ionta, Christopher, Isenhour, Cheryl, Jacobs, Max, Slifka, Kara Jacobs, Jernigan, Daniel, Jhung, Michael, Jones-Wormley, Jamie, Kambhampati, Anita, Kamili, Shifaq, Kennedy, Pamela, Kent, Charlotte, Killerby, Marie, Kim, Lindsay, Kirking, Hannah, Koonin, Lisa, Koppaka, Ram, Kosmos, Christine, Kuhar, David, Kuhnert-Tallman, Wendi, Kujawski, Stephanie, Kumar, Archana, Landon, Alexander, Lee, Leslie, Leung, Jessica, Lindstrom, Stephen, Link-Gelles, Ruth, Lively, Joana, Lu, Xiaoyan, Lynch, Brian, Malapati, Lakshmi, Mandel, Samantha, Manns, Brian, Marano, Nina, Marlow, Mariel, Marston, Barbara, McClung, Nancy, McClure, Liz, McDonald, Emily, McGovern, Oliva, Messonnier, Nancy, Midgley, Claire, Moulia, Danielle, Murray, Janna, Noelte, Kate, Noonan-Smith, Michelle, Nordlund, Kristen, Norton, Emily, Oliver, Sara, Pallansch, Mark, Parashar, Umesh, Patel, Manisha, Pettrone, Kristen, Pierce, Taran, Pietz, Harald, Pillai, Satish, Radonovich, Lewis, Reagan-Steiner, Sarah, Reel, Amy, Reese, Heather, Rha, Brian, Ricks, Philip, Rolfes, Melissa, Roohi, Shahrokh, Roper, Lauren, Rotz, Lisa, Routh, Janell, Sakthivel, Senthil Kumar, Sarmiento, Luisa, Schindelar, Jessica, Schneider, Eileen, Schuchat, Anne, Scott, Sarah, Shetty, Varun, Shockey, Caitlin, Shugart, Jill, Stenger, Mark, Stuckey, Matthew, Sunshine, Brittany, Sykes, Tamara, Trapp, Jonathan, Uyeki, Timothy, Vahey, Grace, Valderrama, Amy, Villanueva, Julie, Walker, Tunicia, Wallace, Megan, Wang, Lijuan, Watson, John, Weber, Angie, Weinbaum, Cindy, Weldon, William, Westnedge, Caroline, Whitaker, Brett, Whitaker, Michael, Williams, Alcia, Williams, Holly, Willams, Ian, Wong, Karen, Xie, Amy, and Yousef, Anna

Subjects
Health (social science), Epidemiology, Health, Toxicology and Mutagenesis, Immigration, 030230 surgery, 01 natural sciences, Disease Outbreaks, 0302 clinical medicine, State (polity), Health Information Management, Interim, Health care, Immunology and Allergy, Medicine, Infection control, Pharmacology (medical), 030212 general & internal medicine, Full Report, media_common, Transmission (medicine), Health Policy, General Medicine, ComputingMilieux_GENERAL, Practice Guidelines as Topic, Public Health, Medical emergency, Epidemiological Monitoring, Coronavirus Infections, Mainland China, medicine.medical_specialty, media_common.quotation_subject, Pneumonia, Viral, Disease cluster, Health(social science), Betacoronavirus, 03 medical and health sciences, Humans, 0101 mathematics, China, Pandemics, Health policy, Infection Control, Transplantation, SARS-CoV-2, business.industry, Public health, 010102 general mathematics, COVID-19, Outbreak, medicine.disease, United States, Family medicine, Reports from the Cdc: MMWR, Centers for Disease Control and Prevention, U.S, business
Abstract

On December 31, 2019, Chinese health officials reported a cluster of cases of acute respiratory illness in persons associated with the Hunan seafood and animal market in the city of Wuhan, Hubei Province, in central China. On January 7, 2020, Chinese health officials confirmed that a novel coronavirus (2019-nCoV) was associated with this initial cluster (1). As of February 4, 2020, a total of 20,471 confirmed cases, including 2,788 (13.6%) with severe illness,* and 425 deaths (2.1%) had been reported by the National Health Commission of China (2). Cases have also been reported in 26 locations outside of mainland China, including documentation of some person-to-person transmission and one death (2). As of February 4, 11 cases had been reported in the United States. On January 30, the World Health Organization (WHO) Director-General declared that the 2019-nCoV outbreak constitutes a Public Health Emergency of International Concern.† On January 31, the U.S. Department of Health and Human Services (HHS) Secretary declared a U.S. public health emergency to respond to 2019-nCoV.§ Also on January 31, the president of the United States signed a "Proclamation on Suspension of Entry as Immigrants and Nonimmigrants of Persons who Pose a Risk of Transmitting 2019 Novel Coronavirus," which limits entry into the United States of persons who traveled to mainland China to U.S. citizens and lawful permanent residents and their families (3). CDC, multiple other federal agencies, state and local health departments, and other partners are implementing aggressive measures to slow transmission of 2019-nCoV in the United States (4,5). These measures require the identification of cases and their contacts in the United States and the appropriate assessment and care of travelers arriving from mainland China to the United States. These measures are being implemented in anticipation of additional 2019-nCoV cases in the United States. Although these measures might not prevent the eventual establishment of ongoing, widespread transmission of the virus in the United States, they are being implemented to 1) slow the spread of illness; 2) provide time to better prepare health care systems and the general public to be ready if widespread transmission with substantial associated illness occurs; and 3) better characterize 2019-nCoV infection to guide public health recommendations and the development of medical countermeasures including diagnostics, therapeutics, and vaccines. Public health authorities are monitoring the situation closely. As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC and state and local health departments.

Published
2020

5. Case of Yellow Fever Vaccine-Associated Viscerotropic Disease with Prolonged Viremia, Robust Adaptive Immune Responses, and Polymorphisms in CCR5 and RANTES Genes

Author

Pulendran, Bali, Miller, Joseph, Querec, Troy D., Akondy, Rama, Moseley, Nelson, Laur, Oscar, Glidewell, John, Monson, Nathan, Zhu, Tuofu, Zhu, Haiying, Staprans, Sylvija, Lee, David, Brinton, Margo A., Perelygin, Andrey A., Vellozzi, Claudia, Brachman, Philip, Lalor, Susan, Teuwen, Dirk, Eidex, Rachel B., Cetron, Marty, Priddy, Frances, Rio, Carlos Del, Altman, John, and Ahmed, Rafi

Published
2008
Full Text
View/download PDF

6. Neisseria meningitidis Serogroup W-135 Carriage among US Travelers to the 2001 Hajj

Author

Dull, Peter M., Abdelwahab, Jalaa, Sacchi, Claudio T., Becker, Margaret, Noble, Corie A., Barnett, Gwen A., Kaiser, Robyn M., Mayer, Leonard W., Whitney, Anne M., Schmink, Susanna, Ajello, Gloria W., Dolan-Livengood, Jennifer, Stephens, David S., Cetron, Marty S., Popovic, Tanja, and Rosenstein, Nancy E.

Published
2005

8. First reported prairie dog-to-human tularemia transmission, Texas, 2002

Author

Avashia, Swati B., Petersen, Jeannine M., Lindley, Connie M., Schriefer, Martin E., Gage, Kenneth L., Cetron, Marty, DeMarcus, Thomas A., Kim, David K., Buck, Jan, Montenieri, John A., Lowell, Jennifer L., Antolin, Michael F., Kosoy, Michael Y., Carter, Leon G., Chu, May C., Hendricks, Katherine A., Dennis, David T., and Kool, Jacob L.

Subjects
Tularemia -- Research
Abstract

A tularemia outbreak, caused by Francisella tularensis type B, occurred among wild-caught, commercially traded prairie dogs. F. tularensis microagglutination titers in one exposed person indicated recent infection. These findings represent [...]

Published
2004

9. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. (Bioterrorism-Related Anthrax)

Author

Jernigan, Daniel B., Raghunathan, Pratima L., Bell, Beth P., Brechner, Ross, Bresnitz, Eddy A., Butler, Jay C., Cetron, Marty, Cohen, Mitch, Doyle, Timothy, Fischer, Marc, Greene, Carolyn, Griffith, Kevin S., Guarner, Jeannette, Hadler, James L., Hayslett, James A., Meyer, Richard, Petersen, Lyle R., Phillips, Michael, Pinner, Robert, Popovic, Tanja, Quinn, Conrad P., Reefhuis, Jennita, Reissman, Dori, Rosenstein, Nancy, Schuchat, Anne, Shieh, Wun-Ju, Siegal, Larry, Swerdlow, David L., Tenover, Fred C., Traeger, Marc, Ward, John W., Weisfuse, Isaac, Wiersma, Steven, Yeskey, Kevin, Zaki, Sherif, Ashford, David A., Perkins, Bradley A., Ostroff, Steve, Hughes, James, Fleming, David, Koplan, Jeffrey P., and Gerberding, Julie L.

Subjects
Company legal issue, Infection, Anthrax -- Diagnosis, Anthrax -- Health aspects, Anthrax -- Prevention, Anthrax -- Case studies, Bioterrorism -- Cases, Bioterrorism -- Health aspects, Biological weapons -- Usage, Public health -- Safety and security measures, Patients -- Care and treatment, Patients -- Health aspects, Patients -- Medical examination, Occupational diseases -- Health aspects
Abstract

In October 2001, the first inhalational anthrax case in the United States since 1976 was identified in a media company worker in Florida. A national investigation was initiated to identify [...]

Published
2002

11. Elevation as a proxy for mosquito-borne Zika virus transmission in the Americas

Author

Watts, Alexander G., primary, Miniota, Jennifer, additional, Joseph, Heather A., additional, Brady, Oliver J., additional, Kraemer, Moritz U. G., additional, Grills, Ardath W., additional, Morrison, Stephanie, additional, Esposito, Douglas H., additional, Nicolucci, Adriano, additional, German, Matthew, additional, Creatore, Maria I., additional, Nelson, Bradley, additional, Johansson, Michael A., additional, Brunette, Gary, additional, Hay, Simon I., additional, Khan, Kamran, additional, and Cetron, Marty, additional

Published
2017
Full Text
View/download PDF

12. Neisseria meningitidisSerogroup W‐135 Carriage among US Travelers to the 2001 Hajj

Author

Dull, Peter M., primary, Abdelwahab, Jalaa’, additional, Sacchi, Claudio T., additional, Becker, Margaret, additional, Noble, Corie A., additional, Barnett, Gwen A., additional, Kaiser, Robyn M., additional, Mayer, Leonard W., additional, Whitney, Anne M., additional, Schmink, Susanna, additional, Ajello, Gloria W., additional, Dolan‐Livengood, Jennifer, additional, Stephens, David S., additional, Cetron, Marty S., additional, Popovic, Tanja, additional, and Rosenstein, Nancy E., additional

Published
2005
Full Text
View/download PDF

13. Quarantine: Voluntary or Not?

Author

Gostin, Lawrence O., primary, Gravely, Steven D., additional, Shakman, Steve, additional, Markel, Howard, additional, and Cetron, Marty, additional

Published
2004
Full Text
View/download PDF

15. Acute pulmonary schistosomiasis in travelers: Case report and review of the literature.

Author

Pavlin, Boris I., Kozarsky, Phyllis, and Cetron, Marty S.

Abstract

We report the case of an American traveler who developed acute pulmonary schistosomiasis after swimming in a lake in Madagascar, and we review the literature on acute pulmonary schistosomiasis. Schistosomiasis is one of the world's most prevalent parasitic diseases, with three species (Schistosoma mansoni, Schistosoma haematobium and Schistosoma japonicum) causing the greatest burden of disease. Pulmonary manifestations may develop in infected travelers from non-endemic areas after their first exposure. The pathophysiology of acute pulmonary disease is not well-understood, but is related to immune response, particularly via inflammatory cytokines. Diagnosis of schistosomiasis may be either through identification of characteristic ova in urine or stool or through serology. Anti-inflammatory drugs can provide symptomatic relief; praziquantel, the mainstay of chronic schistosomiasis treatment, is likely not effective against acute disease; the only reliable prevention remains avoidance of contaminated freshwater in endemic areas, as there is no vaccine. Travelers who have been exposed to potentially contaminated freshwater in endemic areas should seek testing and, if infected, treatment, in order to avoid severe manifestations of acute schistosomiasis and prevent complications of chronic disease. Clinicians are reminded to elicit a detailed travel and exposure history from their patients. [ABSTRACT FROM AUTHOR]

Published
2012
Full Text
View/download PDF

16. ZIKA VIRUS DISEASE AMONG TRAVELERS RETURNING FROM THE AMERICAS BETWEEN JANUARY 2013 AND FEBRUARY 2016: A GEOSENTINEL ANALYSIS

Author

Hamer, Davidson H., Barbre, Kira, Anderson, Susan, Barnett, Elizabeth D., Boggild, Andrea, Bottieau, Emmanuel, Brunette, Gary, Caumes, Eric, Cetron, Marty, Chen, Lin H., Eperon, Gilles, Philippe Gautret, Goorhuis, Abraham, Grobusch, Martin P., Hagmann, Stefan, Hynes, Noreen, Kozarsky, Phyllis, Jespersen, Sanne, Libman, Michael, Lopez-Velez, Rogelio, Malvy, Denis, Mockenhaupt, Frank, Molina, Israel, Perret, Cecilia, Rothe, Camilla, Schlagenhauff, Patricia, Schwartz, Eli, Genderen, Perry, Wilder-Smith, Annelies, Esposito, Doug, Service des maladies infectieuses et tropicales [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Unité de Recherche sur les Maladies Infectieuses Tropicales Emergentes (URMITE), Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, INSB-INSB-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, INSB-INSB-Centre National de la Recherche Scientifique (CNRS), Emory University [Atlanta, GA], Unité de Recherche en Epidémiologie Nutritionnelle, UMR U557 Inserm, U1125 INRA, Cnam, CRNH IdF, Université Paris 13 (UP13), Laboratoire de Photophysique et Photochimie Supramoléculaires et Macromoléculaires (PPSM), École normale supérieure - Cachan (ENS Cachan)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Department of Public Health and Clinical Medicine, Umeå University, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS), and COMBE, Isabelle

Subjects
[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Abstract

65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH), Atlanta, GA, NOV 13-16, 2016; International audience

17. State and Territorial Ebola Screening, Monitoring, and Movement Policy Statements - United States, August 31, 2015.

Author

Sunshine G, Pepin D, Cetron M, and Penn M

Subjects
Africa, Western epidemiology, Centers for Disease Control and Prevention, U.S., District of Columbia, Guidelines as Topic, Hemorrhagic Fever, Ebola epidemiology, Humans, United States, Disease Outbreaks prevention & control, Health Policy, Hemorrhagic Fever, Ebola prevention & control, Mass Screening, Population Surveillance, Travel
Published
2015
Full Text
View/download PDF

18. Airport exit and entry screening for Ebola--August-November 10, 2014.

Author

Brown CM, Aranas AE, Benenson GA, Brunette G, Cetron M, Chen TH, Cohen NJ, Diaz P, Haber Y, Hale CR, Holton K, Kohl K, Le AW, Palumbo GJ, Pearson K, Phares CR, Alvarado-Ramy F, Roohi S, Rotz LD, Tappero J, Washburn FM, Watkins J, and Pesik N

Subjects
Africa, Western epidemiology, Hemorrhagic Fever, Ebola epidemiology, Humans, Risk Assessment, United States epidemiology, Airports, Epidemics prevention & control, Hemorrhagic Fever, Ebola prevention & control, Mass Screening statistics & numerical data, Travel
Abstract

In response to the largest recognized Ebola virus disease epidemic now occurring in West Africa, the governments of affected countries, CDC, the World Health Organization (WHO), and other international organizations have collaborated to implement strategies to control spread of the virus. One strategy recommended by WHO calls for countries with Ebola transmission to screen all persons exiting the country for "unexplained febrile illness consistent with potential Ebola infection." Exit screening at points of departure is intended to reduce the likelihood of international spread of the virus. To initiate this strategy, CDC, WHO, and other global partners were invited by the ministries of health of Guinea, Liberia, and Sierra Leone to assist them in developing and implementing exit screening procedures. Since the program began in August 2014, an estimated 80,000 travelers, of whom approximately 12,000 were en route to the United States, have departed by air from the three countries with Ebola transmission. Procedures were implemented to deny boarding to ill travelers and persons who reported a high risk for exposure to Ebola; no international air traveler from these countries has been reported as symptomatic with Ebola during travel since these procedures were implemented.

Published
2014

Catalog

Books, media, physical & digital resources
See catalog results